MARKETS / NASDAQ / PGNY
NASDAQ · SERVICES-MISC HEALTH & ALLIED SERVICES, NEC · LARGE CAP

Progyny, Inc. PGNY

9 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$1.3B
▲ 10.4% vs FY2024
EPS · FY25
$0.65
Dividend / sh · FY25
Payout · FY25
ROE · FY25
12.5%
Net margin · FY25
4.5%
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.3B
Revenue, FY2025 · full 9-year series below
Revenue Net income
0.40.81.21.61.30.12017202020232025
0.40.81.21.61.30.12017202020232025

5 cents of every revenue dollar became profit this year.

Per share
USD 0.65
Diluted EPS, FY2025
EPS
0.40.81.20.652017202020232025
0.40.81.20.652017202020232025

The company pays no cash dividend.

Profitability
12.5%
Return on equity, FY2025
ROE
1020304012.5%2017202020232025
1020304012.5%2017202020232025
Operating margin6.6%
Net margin4.5%
Return on assets8.7%

Each USD of equity produced 12 cents of profit this year.

Returned to shareholders
USD 81.6M
returned in FY2025 · dividends + net buybacks
Dividends paid
Net buybacksUSD 81.6M
Share of profit139.4%
Consecutive raises

USD 81.6M in buybacks — 139% of the year's profit, so the payout drew on cash built up earlier.

Growth
+30.2% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+17.9%
+30.2%
Net income
+24.5%
+4.7%
EPS, diluted
+29.4%
+6.7%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.08B
Shares outstanding, FY2025
0.010.082017202020232025
0.010.082017202020232025
Change, 5 years−4.2%
Change, 10 years

The share count shrank 4% in five years — the same company, cut into fewer, larger slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 742.4M
total assets, end of FY2025
Total assetsUSD 742.4M
EquityUSD 516.0M
CashUSD 112.2M
Current ratio2.73×

Equity funds 70% of total assets.

History
9 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue $B
1.3
1.2
1.1
0.8
0.5
0.3
0.2
0.1
0.0
Operating income $B
0.1
0.1
0.1
0.0
0.0
0.0
0.0
−0.0
−0.0
EBITDA $B
0.1
0.1
0.1
0.0
0.0
0.0
0.0
−0.0
−0.0
Income tax $B
0.0
0.0
0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
Net income $B
0.1
0.1
0.1
0.0
0.1
0.0
−0.0
0.0
−0.0
EPS, diluted $
0.65
0.57
0.62
0.30
0.66
0.47
−0.41
0.04
−2.37
Dividend / sh $
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
ROE %
12.5
11.1
13.3
9.7
31.4
33.0
−89.5
·
·
Shares out B
0.08
0.09
0.10
0.09
0.09
0.09
0.08
0.01
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
34 of 34
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed